Epigenetics is a biological process that controls how genes are expressed. If the process goes wrong this can lead to disease including cancer, dementia and even developmental abnormalities in children. Scientists are unravelling the mechanisms controlling epigenetics, and have discovered that chemical modifications to proteins and DNA that occur when the epigenetic process goes wrong can be changed or reversed using medicines. Like the genetics revolution where the human genome was decoded, our epigenome (controlled by epigenetic processes) also offers a way of diagnosing disease and monitoring response to drugs. However, unlike the genome, the epigenome is very dynamic and underdoes constant changes, and this can be monitored using special tests. This project brings together Porvair (UK) and Tianlong (China), two companies that have complementary technologies to analyse epigenetic processes. Together, and in partnership with Swansea and Xian Jaotong (Suzhou) universities, they will develop new products to speed up and simplify the study of epigenetics. Ultimately this will allow researchers and diagnostic labs to deliver significant advances in this exciting and important area in the UK and China.